David Feria

Associate Vice President, Quality Operations at Lyra Therapeutics

David Feria has a comprehensive and diverse work experience in the field of quality assurance and regulatory compliance. David has held various roles in different organizations, demonstrating a strong knowledge of quality management systems and regulatory standards. David's most recent role was as the Associate Vice President of Quality Operations at Lyra Therapeutics, starting in 2024. Prior to that, they worked at Seres Therapeutics in roles such as Senior Director of Quality Assurance and Director of Quality Assurance, where they developed and established Quality Management Systems for donation processes. David also gained experience as a Senior Compliance Auditor at Haemonetics, conducting compliance audits worldwide. David has a background in regulatory inspections and investigations, having worked as a Consumer Safety Officer at the FDA. David also served as the Chief of Regulatory and Clinical Compliance at the Department of Veterans Affairs, overseeing electronic systems and equipment validation. Additionally, they worked as a Senior Biomedical Auditor at the American Red Cross National Headquarters and as a Quality Project Specialist at NHS Blood and Transplant. Earlier in their career, David was the Manager of Audits and Quality Assurance at the Indiana Blood Center, where they implemented an audit program and managed the training program for laboratory staff. Overall, David Feria has a wealth of experience in quality assurance and regulatory compliance, showcasing their expertise in developing and implementing quality management systems and conducting audits.

David Feria completed their undergraduate education at the University of Arizona from 1989 to 1995, earning a Bachelor of Science degree in Psychology and Microbiology. David also obtained a certification in Certified Quality Auditor from ASQ in 2001.

Links

Previous companies

Haemonetics logo

Timeline

  • Associate Vice President, Quality Operations

    January, 2024 - present